常规剂量与低剂量CT联合或不联合深度学习去噪在实性小肾癌主动监测中的一致性:多观察者研究
本回顾性研究纳入70例主动监测的小肾癌患者,由3家机构9名放射科医师独立评估350次CT扫描。模拟75%和90%剂量降低显示,75%剂量降低与常规剂量测量一致,而90%降低损害可重复性,深度学习去噪可在亚毫西弗水平保持可重复性并改善图像质量。
要点
- 75%剂量降低的CT与常规剂量在测量小肾癌直径时一致,一致性界限为±2.4 mm vs ±2.2 mm。
- 90%剂量降低损害测量可重复性(一致性界限±3.0 mm),但联合深度学习去噪可恢复至±2.4 mm。
- 深度学习去噪在降低剂量水平下有效恢复图像质量,LD75-DLD整体图像质量最高、噪声更低、对比噪声比更优。
核心结论
- 使用常规迭代重建技术时,75%辐射剂量降低可用于主动监测中小肾癌的CT评估,而应用深度学习去噪可实现亚毫西弗剂量降低。
研究设计与样本
- 回顾性研究,纳入70例主动监测的小肾癌患者(平均年龄73.2岁±9.2,男48例、女22例),由3家机构9名放射科医师独立评估350次CT扫描的5个数据集,参考标准为常规剂量CT。
诊断标准与关键数值
- LD75与常规剂量评估小肾癌直径一致,一致性界限为±2.4 mm(95%CI:2.3,2.6)vs ±2.2 mm(95%CI:2.1,2.4)。
- 90%剂量降低损害可重复性,一致性界限为±3.0 mm(95%CI:2.8,3.2)。
- LD90-DLD保持测量可重复性,一致性界限为±2.4 mm(95%CI:2.3,2.6)。
- 肿瘤与集合系统邻近度和肿瘤形状不规则性的观察者间一致性在所有图像集间相当,无统计学显著差异(肿瘤与集合系统邻近度所有比较P≥.35,肿瘤形状不规则性所有比较P≥.02;Holm校正显著性阈值为P=.013)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the agreement between routine-dose (RD) and lower-dose (LD) contrast-enhanced CT scans, with and without Digital Imaging and Communications in Medicine-based deep learning-based denoising (DLD), in evaluating small renal masses (SRMs) during active surveillance. Materials and Methods In this retrospective study, CT scans from patients undergoing active surveillance for an SRM were included. Using a validated simulation technique, LD CT images were generated from the RD images to simulate 75% (LD75) and 90% (LD90) radiation dose reductions. Two additional LD image sets, in which the DLD was applied (LD75-DLD and LD90-DLD), were generated. Between January 2023 and June 2024, nine radiologists from three institutions independently evaluated 350 CT scans across five datasets for tumor size, tumor nearness to the collecting system (TN), and tumor shape irregularity (TSI), and interobserver reproducibility and agreement were assessed using the 95% limits of agreement with the mean (LOAM) and Gwet AC2 coefficient, respectively. Subjective and quantitative image quality assessments were also performed. Results The study sample included 70 patients (mean age, 73.2 years ± 9.2 [SD]; 48 male, 22 female). LD75 CT was found to be in agreement with RD scans for assessing SRM diameter, with a LOAM of ±2.4 mm (95% CI: 2.3, 2.6) for LD75 compared with ±2.2 mm (95% CI: 2.1, 2.4) for RD. However, a 90% dose reduction compromised reproducibility (LOAM ±3.0 mm; 95% CI: 2.8, 3.2). LD90-DLD preserved measurement reproducibility (LOAM ±2.4 mm; 95% CI: 2.3, 2.6). Observer agreement was comparable between TN and TSI assessments across all image sets, with no statistically significant differences identified (all comparisons P ≥ .35 for TN and P ≥ .02 for TSI; Holm-corrected significance threshold, P = .013). Subjective and quantitative image quality assessments confirmed that DLD effectively restored image quality at reduced dose levels: LD75-DLD had the highest overall image quality, significantly lower noise, and improved contrast-to-noise ratio compared with RD (P < .001). Conclusion A 75% reduction in radiation dose is feasible for SRM assessment in active surveillance using CT with a conventional iterative reconstruction technique, whereas applying DLD allows submillisievert dose reduction. Keywords: CT, Urinary, Kidney, Radiation Safety, Observer Performance, Technology Assessment Supplemental material is available for this article. © RSNA, 2025 See also commentary by Muglia in this issue.
引用
- Borgbjerg J, Breen BS, Kristiansen CH, et al. Agreement between Routine-Dose and Lower-Dose CT with and without Deep Learning-based Denoising for Active Surveillance of Solid Small Renal Masses: A Multiobserver Study. Radiol Imaging Cancer. 2025. PMID: 40512032. doi:10.1148/rycan.240250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。